Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors

NCT04906473 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: KY100001

Sponsor

Kunming Pharmaceuticals, Inc.